Science
It's a 2-for-1 podcast as Dr Mattias Lissing of the Karolinska Institute joins us to discuss two recent papers looking at cancer risk, comorbidity and mortality in the acute porphyrias.
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals
Mattias Lissing, et al
https://doi.org/10.1002/jimd.12583
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients
Mattias Lissing, et al
https://doi.org/10.1002/jimd.12676
view more
More Episodes
Treatment In Alkaptonuria
2022-03-25
2022-03-25
Arginase Deficiency
2022-03-11
2022-03-11
Unravelling the Secrets Of PMM2-CDG
2022-02-11
2022-02-11
Transplant Outcomes in X-ALD
2022-01-27
2022-01-27
100 Years Of IMD (in Austria)
2021-12-31
2021-12-31
Organoids in IMD
2021-12-03
2021-12-03
MPS 1: Where are we now?
2021-11-04
2021-11-04
Easy as ABC...D3
2021-11-04
2021-11-04
Gene Therapy in CBS Deficiency
2021-09-27
2021-09-27
The Young Metabolists Society
2021-07-16
2021-07-16
Get this podcast on your
phone, FREE
